Latest News about FDA
Recent news which mentions FDA
After FDA Rejection, Spectrum Shelves Development On Poziotinib
November 25, 2022
Tickers
SPPI
From Benzinga
From Benzinga
Canceled AdCom, UniQure's Hemgenix Approval Show Positive Signs For BioMarin's Hemophilia Candidate
November 23, 2022
Tickers
BMRN
From Benzinga
DEA Legalizes Cocaine Derivative As Diagnostic Aid For Parkinson's, Ignoring Cannabis Experts Seeking Same
November 23, 2022
Tickers
DEA
From Benzinga
Psychedelics And Treatment-Resistant Depression: Companies Weigh In On The Important Issue
November 23, 2022
From Benzinga
From Benzinga
From Benzinga
After Disappointing Confirmatory Study, GSK To Withdraw Approved Blood Cancer Drug In US
November 22, 2022
Tickers
GSK
From Benzinga
Philips Flags Two Additional Issues With Reworked, Placed Ventilators
November 22, 2022
Tickers
PHG
From Benzinga
Argenx's Flagship Neuromuscular Treatment For Subcutaneous Injection Goes Under Priority FDA Review
November 22, 2022
From Benzinga
Independent Director Jennifer Crandall to Speak about FDA's New FSMA 204 Regulation
November 22, 2022
Tickers
PCYG
OKYO Pharma Files US IND Application For Dry Eye Disease Candidate
November 21, 2022
Tickers
OKYO
From Benzinga
Psychedelics Move Forward In Congress: Sens. Booker And Paul File 'Breakthrough Therapies Act'
November 18, 2022
From Benzinga
Apellis Pharma Shares Jump As FDA Accepts Its Lead Product Application For Eye Disease
November 18, 2022
Tickers
APLS
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.